A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " BoZo Research Center Inc.

BoZo Research Center Inc.

Table of Contents
Table of Contents

BoZo Research Center Inc. supports optimizing lead compounds.
This page provides a detailed overview of their non-clinical study capabilities, examples of disease models, and case studies.
It serves as a useful reference when selecting a CRO(contract research organization).

Features of BoZo Research Center Inc.’s Non-Clinical Study Services

Comprehensive Development Support Platform

BoZo Research Center Inc. offers comprehensive non-clinical testing service for a wide range of drug development projects, including in pharmaceuticals, agrochemicals, and food products.
Their service encompasses pharmacological, toxicological, and analytical studies by specialists in each field.
They provide consistent support from the early drug discovery phase to commercialization phase.

Extensive Testing Experience and Expertise

The center has a proven track record in providing non-clinical studies.They are especially recognized for their research in cancer and metabolic diseases, offering extensive in vivo and in vitro testing using various disease models.
Consulting services by the team of experts are also available.

Compliance with the 3R Principles

Non-clinical studies at BoZo Research Center Inc. are conducted with a strong commitment to animal welfare, following the 3R (Replacement, Reduction, and Refinement) principles.
The center is fully accredited by AAALAC International, and all of their facilities are compliant to GLP standards, which ensures that studies are performed in a safe and ethical environment.

Examples of Disease Models at BoZo Research Center Inc.

It is essential to go through the testing of candidate compounds in animal models that reproduce the target disease before advancing to clinical trials.

However, clinically relevant disease models may not always exist, thus there are demands for animal models with strong clinical correlation.

Below are some examples of disease models offered at Ina Research.

Allergic Rhinitis Model

Guinea pigs sensitized with OVA are used to evaluate drug effects on acute/chronic nasal reactions—such as rhinitis and nasal obstruction—induced by intranasal antigen administration, as well as on inflammatory cell infiltration in the nasal cavity.
Rats can also be used for efficacy studies on increased vascular permeability in the nasal mucosa.

Asthma Model

Guinea pigs sensitized with OVA are used to examine drug effects on acute/chronic asthmatic reactions and airway obstruction induced by antigen inhalation, as well as on inflammatory cell infiltration in the airway lumen.
Mouse models are also available to investigate airway hyperresponsiveness and airway remodeling.

Non-Clinical Study Case Examples

Respiratory System Studies

Pharmacological and medical device performance evaluations are also available by experienced researchers at BoZo Research Center Inc..
There are models for rhinitis, asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.
For COPD evaluations, various pathological models are available, including tobacco solution administration models (guinea pigs) and tobacco smoke exposure models (mice, rats, and guinea pigs).

Company Information

BoZo Research Center Inc. provides tailored solutions that meet the needs of pharmaceutical companies, medical device manufacturers, academic institutions, bio-ventures, and medical organizations.

Address 36-7 Oyama-cho, Shibuya-ku, Tokyo
Tel 03-5453-8101
Website https://www.bozo.co.jp/
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
Labcorp Holdings Inc.
(Labcorp Drug Development)
Labcorp Holdings Inc.
Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)
  • Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd.
Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

By region
list of animal models
Expertise & Track Record
3 Recommended Contract Non-Clinical Testing Services